Related Experiment Video
Updated: Apr 27, 2026

Preparation and In Vitro Characterization of Dendrimer-based Contrast Agents for Magnetic Resonance Imaging
Published on: December 4, 2016
Natural D-glucose as a biodegradable MRI relaxation agent
Nirbhay N Yadav1, Jiadi Xu, Amnon Bar-Shir
1Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; F.M. Kirby Research Center for Functional Brain Imaging, Kennedy Krieger Research Institute, Baltimore, Maryland, USA.
Researchers investigated whether common sugar, D-glucose, could serve as a safe, biodegradable alternative to synthetic contrast agents for magnetic resonance imaging. By testing various concentrations and acidity levels, they found that glucose effectively alters magnetic resonance signals, particularly at physiological pH. Experiments in blood and living mice confirmed that glucose infusion creates detectable changes in image contrast that recover quickly. These findings suggest that natural sugar might offer a non-toxic option for clinical imaging procedures.
Area of Science:
- Medical imaging research within D-glucose diagnostic applications
- Biomedical engineering and contrast agent development
Background:
No prior work had resolved whether common dietary sugars could function effectively as safe, biodegradable alternatives for clinical diagnostic imaging. That uncertainty drove researchers to investigate the magnetic properties of simple carbohydrates. It was already known that synthetic contrast agents often carry risks of toxicity or long-term retention in patients. This gap motivated the exploration of endogenous molecules that the human body can safely metabolize. Prior research has shown that magnetic resonance imaging relies on precise relaxation rates to generate clear anatomical pictures. However, standard agents are frequently metallic and require careful monitoring for adverse reactions. That limitation encouraged scientists to look toward natural substances already approved for human administration. No prior work had resolved if these substances could provide sufficient signal modulation for high-quality diagnostic scans.
Purpose Of The Study:
The aim of this work was to demonstrate the applicability of natural sugar as a T2 magnetic resonance imaging contrast agent. Researchers sought to determine if this common molecule could safely enhance diagnostic image quality. They addressed the challenge of finding non-toxic alternatives to existing synthetic contrast materials. The motivation was to utilize substances already approved for human administration to improve patient safety. By testing various concentrations, the team explored the limits of signal modulation. They also investigated how environmental acidity influences the effectiveness of the agent. This study sought to bridge the gap between basic chemical properties and practical diagnostic utility. The researchers intended to provide a clear assessment of whether this biodegradable option could perform reliably in clinical settings.
Main Methods:
The team prepared aqueous solutions across a range of concentrations and acidity levels to assess magnetic properties. They utilized high-field spectrometers operating at 3, 7, and 11.7 T to quantify relaxation rates. To evaluate biological relevance, they conducted additional assessments using human blood samples. The researchers performed in vivo trials by infusing a mouse model with the agent. They captured dynamic images of the abdominal region to monitor signal changes over time. This approach involved calculating transverse relaxation rates to determine the efficacy of the substance. They compared their empirical data against theoretical predictions derived from established physical equations. The investigators ensured that all experimental conditions mimicked physiological environments to maintain clinical applicability.
Main Results:
The strongest finding indicates that transverse relaxation rates show a robust dependence on both concentration and acidity. A maximum change in these rates occurred within the physiological range of pH 6.8 to 7.8. At 22°C and pH 7.3, the team recorded transverse relaxivities of 0.021, 0.060, and 0.077 s(-1) mM(-1) at 3.0, 7.0, and 11.7 T. These empirical values demonstrated strong agreement with predictions from the Swift-Connick equation. In contrast, longitudinal relaxation and diffusion coefficients showed no significant sensitivity to concentration or pH variations. The transverse relaxivity measured in blood reached 0.09 s(-1) mM(-1) at 11.7 T. During in vivo testing, the researchers observed a 10% drop in signal intensity immediately following infusion. This signal intensity returned to baseline levels within a period of 50 to 100 seconds.
Conclusions:
The authors propose that natural sugar serves as a viable, biodegradable alternative for magnetic resonance imaging contrast enhancement. Their synthesis suggests that the observed signal changes align well with established physical models of molecular interaction. The researchers imply that using substances already approved for human consumption could streamline future clinical translation. They note that the observed signal recovery in living models supports the safety profile of this approach. The team indicates that the dependence on physiological acidity levels is a key factor for future diagnostic design. They conclude that the measured relaxation rates provide a clear framework for optimizing image sensitivity. The study suggests that this method avoids the toxicity concerns associated with traditional metallic agents. Finally, the authors maintain that their findings offer a foundation for developing non-invasive, patient-friendly diagnostic tools.
Frequently Asked Questions
The researchers propose that D-glucose acts as a T2 contrast agent by altering the transverse relaxation rate of water protons. This mechanism depends on the concentration of the sugar and the acidity of the surrounding environment, specifically showing peak efficacy near physiological pH levels.
The team utilized the Swift-Connick equation to validate their experimental findings. This mathematical model allowed them to compare observed transverse relaxivity values against theoretical predictions across different magnetic field strengths, confirming the reliability of their measurements.
A magnetic field strength of 11.7 T was necessary to evaluate the agent in blood samples. This high-field environment provided the sensitivity required to distinguish the specific relaxivity of 0.09 s(-1) mM(-1) in a complex biological fluid.
The researchers used dynamic T2-weighted imaging to track the agent in vivo. This data type allowed them to observe a 10% reduction in signal intensity following infusion, followed by a return to baseline levels within 50 to 100 seconds.
The study measured transverse relaxivities at 22°C and pH 7.3, finding values of 0.021, 0.060, and 0.077 s(-1) mM(-1) at 3.0, 7.0, and 11.7 T, respectively. These results demonstrate that signal enhancement increases with higher magnetic field strengths.
The authors suggest that because glucose is already approved for human use, this approach could bypass lengthy safety trials required for synthetic agents. They propose that this strategy offers a non-toxic, biodegradable alternative to traditional contrast materials currently used in clinical practice.
More Related Videos
Related Concept Videos
Magnetic Resonance Imaging
Imaging Studies I: CT and MRI
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
Imaging Studies for Cardiovascular System IV: CMRI

